# TUPKRP Combined With MAB Therapy for LUTS/PCa

> **NCT03701659** · NA · UNKNOWN · sponsor: **The Third Xiangya Hospital of Central South University** · enrollment: 100 (estimated)

## Conditions studied

- Advanced Prostate Cancer
- Lower Urinary Tract Symptoms
- Quality of Life
- Overall Survival
- Progression of Prostate Cancer

## Interventions

- **PROCEDURE:** Surgery combinate with Endocrine therapy
- **DRUG:** Endocrine therapy

## Key facts

- **NCT ID:** NCT03701659
- **Lead sponsor:** The Third Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-01
- **Primary completion:** 2023-11-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03701659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03701659, "TUPKRP Combined With MAB Therapy for LUTS/PCa". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT03701659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*